Our Drug Discovery Services Include:
- Medicinal chemistry -Lead Generation: Enhanced Rational Drug Design and Fast-Track Hit Validation
- Medicinal chemistry -Multiparametric Lead Optimization: Better Candidates in Less Time
- Synthetic and Custom Chemistry: When you know what you want but lack the internal capacity to make it
- Explora ADMET: Extensive in vitro developability and toxicology assays
- in vivo PK: evaluation of compounds and MALDI ToF/ToF Mass spectroscopy Imaging to give you detailed distribution for your drug
- In vitro Pharmacology: now offered as a standalone service
- In vivo Pharmacology: an expanding service, watch our news
- GCP and GLP Bioanalysis: for supporting your post candidate studies
- In vivo Toxicology : for critical preclinical development studies
Our Services: Focused on Drug Discovery
NiKem Research Services for fast, efficient, high quality results
Our objective is to help you move your projects from discovery into late preclinical evaluation as rapidly as possible. We focus on efficiency by using all of our expertise and capabilities from in silico prediction and medicinal chemistry to in vitro ADME and pharmacology and in vivo PK and PK/PD evaluation, to ensure high quality data and fast, efficient decision making. Our approach aims to maximise value for our clients and to reduce downstream development risks as much as possible.
Now our newly introduced GLP bioanalysis and toxicology services extend our integrated drug discovery services into preclinical development. In addition NiKem has been granted licenses to be able to offer Clinical (GCP) Bioanalysis services to support our clients clinical studies.
All our services are available either standalone or at various levels of integration thorough a range of flexible business models.
NiKem Research business models
For more information please contact: info@nikemresearch.com